한선욱

  #유방암#갑상선암 클리닉#내분비외과

학력

순천향대학교 의과대학
순천향대학교 대학원(석사)

경력

2007 ~ 현재 : 순천향대학교 부속 천안병원 교수

논문

Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy (ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2018)

Development of second primary cancer in Korean breast cancer survivors (ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2017)

Clinicopathologic and Prognostic Significance of Transducin-Like Enhancer of Split 1 Protein Expression in Invasive Breast Cancer (JOURNAL OF BREAST CANCER, 2017)

Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer. (JOURNAL OF BREAST CANCER, 2016)

Prediction of risk for symptomatic sialadenitis by post-therapeutic dual 131I scintigraphy in patients with differentiated thyroid cancer(Ann Nucl Med)

Toxicity and quality of life of Korean breast cancer patients treated with docetaxel-containing chemotherapy without primary G-CSF prophylaxis(Breast Cancer)

BRAF (V600E) Mutation Analysis in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-time PCR(Ann Surg Oncol)

Association between Preoperative Serum TSH Level and Papillary Thyroid Cancers(대한내분비외과학회지, 12(3):166-71)

Hyalinizing Trabecular Tumor of the Thyroid gland(대한내분비외과학회지, 12(2):112-4)

저서

저서 내용이 없습니다.

보도자료

예후좋은 착한癌... 안심하다 치명타
http://www.cctoday.co.kr/news/articleView.html?idxno=932633

포스팅

포스팅 내용이 없습니다.

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.